by | Jul 11, 2024 | Lupus Foundation of America, News & Events
A complex and mysterious disease, the causes of systemic lupus erythematosus (SLE) remain unknown. In a new study, researchers discovered a mechanism that may contribute to lupus development and a possible new approach to reverse or cure the disease. Scientists...
by | Jul 11, 2024 | Lupus Foundation of America, News & Events
There is growing recognition that diet and nutrient consumption influence inflammation and disease progression in people with systemic lupus erythematosus (SLE). In a recent study, researchers examined the intake of ultra-processed food (UPF) and the incidence of SLE...
by | Jul 2, 2024 | Lupus Foundation of America, News & Events
A multi-center clinical trial of investigational therapy, NKX019, for the treatment of lupus nephritis (LN, lupus-related kidney disease) is screening its first participant. The Ntrust-1 study is designed to initially enroll up to 12 participants with refractory LN...
by | Jun 19, 2024 | Lupus Foundation of America, News & Events
Initial Phase 1 of 2 RESET-Myositis and RESET-SLE clinical trial data of the investigational therapy, CABA-201, revealed positive outcomes. The first two study participants did not exhibit infections or serious adverse events and complete B cell depletion was observed...
by | Jun 18, 2024 | Lupus Foundation of America, News & Events
Neonatal lupus erythematosus (NLE) is a rare condition in which certain antibodies from the mother are passed to the fetus. A new study explored whether genetics may impact NLE risk and did not find an association between systemic lupus erythematosus (SLE) genetics...
by | Jun 17, 2024 | Lupus Foundation of America
What is RAY? Research Accelerated by You (RAY®) is a patient registry where people living with lupus and their caregivers share their experiences and preferences through an online survey to help researchers better understand lupus. This information is shared...